HIV gp120 interactions with coreceptors: Insights from studies with CCR5-based peptides

被引:0
|
作者
Berger, Edward A.
Alkhatib, Ghalib
机构
[1] NIAID, NIH, Viral Dis Lab, Bethesda, MD 20892 USA
[2] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
关键词
HIV; AIDS; coreceptor; CCR5; CXCR4; chemokine receptor; CD4; GPCR; peptides; fusion; entry;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Human immunodeficiency virus enters cells by a direct fusion mechanism triggered by sequential binding of the gp120 subunit of the envelope glycoprotein, first to CD4, then to the coreceptor CCR5 or CXCR4. The coreceptors are chemokine receptors, members of the superfamily of G protein-coupled receptors that are characterized by 7 transmembrane domains. gp120 is presumed to interact with the extracellular portion, which consists of the N-terminal segment and three extracellular loops. Synthetic peptides based on these regions have proven to be valuable probes for elucidating the molecular details of the complex gp120-coreceptor interactions.
引用
收藏
页码:403 / 407
页数:5
相关论文
共 50 条
  • [21] A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5
    Zhao, Q
    He, YX
    Alespeiti, G
    Debnath, AK
    [J]. VIROLOGY, 2004, 326 (02) : 299 - 309
  • [22] Solution structure of the HIV gp120 C5 domain
    Guilhaudis, L
    Jacobs, A
    Caffrey, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (19): : 4860 - 4867
  • [23] Multivalent Interactions with gp120 Are Required for the Anti-HIV Activity of Cyanovirin
    Liu, Yinan
    Carroll, Jacob R.
    Holt, Lindsey A.
    McMahon, James
    Giomarelli, Barbara
    Ghirlanda, Giovanna
    [J]. BIOPOLYMERS, 2009, 92 (03) : 194 - 200
  • [24] Roles of glycans in interactions between gp120 and HIV broadly neutralizing antibodies
    Qi, Yifei
    Jo, Sunhwan
    Im, Wonpil
    [J]. GLYCOBIOLOGY, 2016, 26 (03) : 251 - 260
  • [25] New insights into the interaction between the gp120 and the HIV receptor in human sperm (human-sperm/gp120/galactoglycerolipid/antigalactosylceramide/seminolipid/spermatogonia)
    Brogi, A
    Presentini, R
    Moretti, E
    Strazza, M
    Piomboni, P
    Costantino-Ceccarini, E
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 41 (1-2) : 213 - 231
  • [26] Evading the immune system: Insights from the crystal structure of the HIV gp120 envelope glycoprotein.
    Kwong, PD
    Wyatt, R
    Sodroski, J
    Hendrickson, WA
    [J]. FASEB JOURNAL, 1999, 13 (07): : A1590 - A1590
  • [27] Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5
    Tam, Kayan
    Schultz, Megan
    Reyes-Robles, Tamara
    Vanwalscappel, Benedicte
    Horton, Joshua
    Alonzo, Francis, III
    Wu, Beili
    Landau, Nathaniel R.
    Torres, Victor J.
    [J]. MBIO, 2016, 7 (06):
  • [28] Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120
    Choe, H
    Li, WH
    Wright, PL
    Vasilieva, N
    Venturi, M
    Huang, CC
    Grundner, C
    Dorfman, T
    Zwick, MB
    Wang, LP
    Rosenberg, ES
    Kwong, PD
    Burton, DR
    Robinson, JE
    Sodroski, JG
    Farzan, M
    [J]. CELL, 2003, 114 (02) : 161 - 170
  • [29] Multiple binding modes of an N-terminal CCR5-peptide in complex with HIV-1 gp120
    Moseri, Adi
    Akabayov, Sabine R.
    Cohen, Leah S.
    Naider, Fred
    Anglister, Jacob
    [J]. FEBS JOURNAL, 2022, 289 (11) : 3132 - 3147
  • [30] Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
    Grainger, DJ
    Lever, AML
    [J]. RETROVIROLOGY, 2005, 2 (1)